Drug intelligence / Profile preview

Caligel

Development stage
Unknown
Lead developer
Alikon
Modality
Small Molecules
Administration
Intra-arterial
01

Overview

Caligel is a topical combination pharmaceutical product formulated as a gel for the treatment of various inflammatory skin disorders complicated by bacterial or fungal infections. It contains three active components: clobetasol propionate, a high-potency corticosteroid; neomycin sulphate, an aminoglycoside antibiotic; and miconazole nitrate, an imidazole antifungal. Clobetasol propionate works by inducing phospholipase A2 inhibitory proteins, thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Neomycin sulphate interferes with bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to the production of nonfunctional proteins and bacterial cell death. Miconazole nitrate inhibits the synthesis of ergosterol, an essential component of fungal cell membranes, by inhibiting the enzyme lanosterol 14-alpha demethylase. This triple-action formulation is primarily indicated for conditions such as infected eczema, psoriasis, and various forms of dermatitis where secondary infection is present or suspected.

Brand names
Caligel
Other names
Clobetasol propionate + Neomycin sulphate + Miconazole nitrate gel
02

Targets

CYP (Cytochrome P450 family)Bacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Caligel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caligel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call